In a filing, Quest Diagnostics, Inc revealed its Officer DELANEY MARK E acquired Company’s shares for reported $0.43 million on Jan 31 ’25. In the deal valued at $164.85 per share,2,615 shares were bought.
Then, PREVOZNIK MICHAEL E sold 35,146 shares, generating $5,731,302 in total proceeds. Upon selling the shares at $163.07, the SVP & General Counsel now owns 38,478 shares.
Before that, Doherty Catherine T. sold 33,103 shares. Quest Diagnostics, Inc shares valued at $5,395,484 were divested by the EVP, Regional Businesses at a price of $162.99 per share. As a result of the transaction, Doherty Catherine T. now holds 68,412 shares, worth roughly $11.11 million.
Leerink Partners upgraded its Quest Diagnostics, Inc [DGX] rating to an Outperform from a a Market perform in a research note published on January 06, 2025; the price target was increased to $174 from $169. A number of analysts have revised their coverage, including Morgan Stanley’s analysts, who increased its forecast for the stock in mid December from “an Equal-weight” to “an Overweight”. Robert W. Baird revised its rating on October 23, 2024. It rated DGX as “an Outperform” which previously was an “a Neutral”.
Price Performance Review of DGX
On Monday, Quest Diagnostics, Inc [NYSE:DGX] saw its stock fall -0.39% to $162.47. Over the last five days, the stock has gained 1.56%. Quest Diagnostics, Inc shares have risen nearly 7.70% since the year began. Nevertheless, the stocks have risen 26.50% over the past one year. While a 52-week high of $167.08 was reached on 01/30/25, a 52-week low of $123.04 was recorded on 01/16/25. SMA at 50 days reached $156.20, while 200 days put it at $149.09.
Levels Of Support And Resistance For DGX Stock
The 24-hour chart illustrates a support level at 160.46, which if violated will result in even more drops to 158.44. On the upside, there is a resistance level at 164.04. A further resistance level may holdings at 165.60. The Relative Strength Index (RSI) on the 14-day chart is 62.65, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 7.55, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 25.08%. Stochastics %K at 79.14% indicates the stock is a holding.
How much short interest is there in Quest Diagnostics, Inc?
A steep rise in short interest was recorded in Quest Diagnostics, Inc stocks on 2025-01-15, growing by 0.36 million shares to a total of 2.27 million shares. Yahoo Finance data shows the prior-month short interest on 2024-12-13 was 1.91 million shares. There was a rise of 15.86%, which implies that there is a positive sentiment for the stock.
